Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Enlivex Therapeutics Cash Flow from Investing Activities 2013-2023 | ENLV

Enlivex Therapeutics cash flow from investing activities from 2013 to 2023. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
  
Enlivex Therapeutics Annual Cash Flow Investing
(Millions of US $)
2023 $-26
2022 $63
2021 $-38
2020 $-21
2019 $-6
2018 $-1
2017 $-0
2016 $9
2015 $10
2014 $-22
2013 $-0
2012 $
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.024B $0.000B
Enlivex is a clinical stage immunotherapy company, developing an allogeneic drug pipeline for immune system rebalancing. Immune system rebalancing is critical for the treatment of life-threatening immune and inflammatory conditions which involve hyper-expression of cytokines (Cytokine Release Syndrome) and for which there are no approved treatments (unmet medical needs), as well as solid tumors immune-checkpoint rebalancing.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.935B 31.69
Chugai Pharmaceutical (CHGCY) Japan $48.297B 21.59
Takeda Pharmaceutical (TAK) Japan $40.953B 8.29
Merck (MKGAF) Germany $23.081B 22.38
Astellas Pharma (ALPMY) Japan $17.463B 27.57
Sandoz Group AG (SDZNY) Switzerland $14.891B 0.00
Neurocrine Biosciences (NBIX) United States $13.548B 37.08
Shionogi (SGIOY) Japan $13.012B 11.31
United Therapeutics (UTHR) United States $11.875B 12.66
Catalent (CTLT) United States $9.697B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.437B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.572B 7.22
Revolution Medicines (RVMD) United States $6.222B 0.00
Orion OYJ (ORINY) Finland $5.637B 23.77
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Ionis Pharmaceuticals (IONS) United States $5.320B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.742B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.613B 0.00
Corcept Therapeutics (CORT) United States $3.283B 29.75
Arrowhead Pharmaceuticals (ARWR) United States $2.840B 0.00
Dyne Therapeutics (DYN) United States $2.716B 0.00
PTC Therapeutics (PTCT) United States $2.687B 0.00
Indivior (INDV) United States $2.487B 11.79
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.093B 11.90
Summit Therapeutics (SMMT) United States $2.060B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.039B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.876B 18.25
Fusion Pharmaceuticals (FUSN) Canada $1.821B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.708B 0.00
Evotec AG (EVO) Germany $1.623B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.595B 23.98
Ardelyx (ARDX) United States $1.538B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.498B 0.00
Soleno Therapeutics (SLNO) United States $1.433B 0.00
Xencor (XNCR) United States $1.430B 0.00
Pacira BioSciences (PCRX) United States $1.362B 12.95
BioCryst Pharmaceuticals (BCRX) United States $1.269B 0.00
4D Molecular Therapeutics (FDMT) United States $1.239B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.130B 0.00
Collegium Pharmaceutical (COLL) United States $1.086B 6.50
Cassava Sciences (SAVA) United States $1.021B 0.00
Enliven Therapeutics (ELVN) United States $1.003B 0.00
Cronos Group (CRON) Canada $0.978B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.944B 14.71
Ocular Therapeutix (OCUL) United States $0.909B 0.00
ProKidney (PROK) United States $0.908B 0.00
USANA Health Sciences (USNA) United States $0.888B 14.52
ARS Pharmaceuticals (SPRY) United States $0.855B 0.00
Relay Therapeutics (RLAY) United States $0.822B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.808B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.736B 0.00
Sage Therapeutics (SAGE) United States $0.654B 0.00
Lyell Immunopharma (LYEL) United States $0.653B 0.00
Silence Therapeutics (SLN) United Kingdom $0.645B 0.00
Harrow (HROW) United States $0.631B 0.00
Savara (SVRA) United States $0.573B 0.00
Exscientia (EXAI) United Kingdom $0.565B 0.00
Bioventus (BVS) United States $0.539B 20.64
OmniAb (OABI) United States $0.535B 0.00
Siga Technologies (SIGA) United States $0.526B 6.73
Lexeo Therapeutics (LXEO) United States $0.500B 0.00
Heron Therapeutics (HRTX) United States $0.493B 0.00
Altimmune (ALT) United States $0.486B 0.00
KalVista Pharmaceuticals (KALV) United States $0.470B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.465B 0.00
Korro Bio (KRRO) United States $0.464B 0.00
Larimar Therapeutics (LRMR) United States $0.451B 0.00
Verve Therapeutics (VERV) United States $0.427B 0.00
Esperion Therapeutics (ESPR) United States $0.411B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.403B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.358B 0.00
Tourmaline Bio (TRML) United States $0.349B 0.00
Organogenesis (ORGO) United States $0.341B 64.25
Fractyl Health (GUTS) United States $0.324B 0.00
Nanobiotix S.A (NBTX) France $0.315B 0.00
Xeris Biopharma Holdings (XERS) United States $0.286B 0.00
ESSA Pharma (EPIX) Canada $0.283B 0.00
Nature's Sunshine Products (NATR) United States $0.282B 17.91
Aquestive Therapeutics (AQST) United States $0.279B 0.00
Century Therapeutics (IPSC) United States $0.269B 0.00
Black Diamond Therapeutics (BDTX) United States $0.267B 0.00
Nektar Therapeutics (NKTR) United States $0.254B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.252B 0.00
CytoDyn (CYDY) United States $0.241B 0.00
Metagenomi (MGX) United States $0.240B 0.00
Foghorn Therapeutics (FHTX) United States $0.240B 0.00
Acrivon Therapeutics (ACRV) United States $0.232B 0.00
Avita Medical (RCEL) United States $0.227B 0.00
Pyxis Oncology (PYXS) United States $0.224B 0.00
Conduit Pharmaceuticals (CDT) United States $0.224B 0.00
Eliem Therapeutics (ELYM) United States $0.223B 0.00
Aldeyra Therapeutics (ALDX) United States $0.220B 0.00
Akebia Therapeutics (AKBA) United States $0.216B 0.00
Elite Pharmaceuticals (ELTP) United States $0.197B 18.40
Adherex Technologies (FENC) United States $0.195B 238.33
Zevra Therapeutics (ZVRA) United States $0.192B 0.00
Telomir Pharmaceuticals (TELO) United States $0.190B 0.00
Incannex Healthcare (IXHL) Australia $0.187B 0.00
Achieve Life Sciences (ACHV) Canada $0.183B 0.00
Prelude Therapeutics (PRLD) United States $0.182B 0.00
Profound Medical (PROF) Canada $0.179B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Galectin Therapeutics (GALT) United States $0.173B 0.00
Cardiol Therapeutics (CRDL) Canada $0.164B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.161B 0.00
MediWound (MDWD) Israel $0.152B 0.00
Context Therapeutics (CNTX) United States $0.150B 0.00
VAXART, INC (VXRT) United States $0.145B 0.00
Regulus Therapeutics (RGLS) United States $0.139B 0.00
OptiNose (OPTN) United States $0.121B 0.00
FibroGen (FGEN) United States $0.116B 0.00
Citius Pharmaceuticals (CTXR) United States $0.114B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.114B 7.59
Karyopharm Therapeutics (KPTI) United States $0.113B 0.00
ProPhase Labs (PRPH) United States $0.098B 0.00
PMV Pharmaceuticals (PMVP) United States $0.093B 0.00
Assertio Holdings (ASRT) United States $0.091B 4.14
Vivani Medical (VANI) United States $0.090B 0.00
Relmada Therapeutics (RLMD) United States $0.088B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
AlloVir (ALVR) United States $0.085B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.085B 0.00
SCYNEXIS (SCYX) United States $0.083B 1.18
Journey Medical (DERM) United States $0.077B 0.00
Tempest Therapeutics (TPST) United States $0.075B 0.00
Aclaris Therapeutics (ACRS) United States $0.072B 0.00
Champions Oncology (CSBR) United States $0.063B 0.00
Protara Therapeutics (TARA) United States $0.060B 0.00
Nutriband (NTRB) United States $0.058B 0.00
Mural Oncology (MURA) Ireland $0.057B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.056B 0.00
BioLineRx (BLRX) Israel $0.055B 0.00
Carisma Therapeutics (CARM) United States $0.054B 0.00
Inotiv (NOTV) United States $0.054B 0.00
CASI Pharmaceuticals (CASI) China $0.049B 0.00
Gain Therapeutics (GANX) United States $0.043B 0.00
DURECT (DRRX) United States $0.042B 0.00
NRx Pharmaceuticals (NRXP) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Rafael Holdings (RFL) United States $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
VYNE Therapeutics (VYNE) United States $0.037B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.036B 0.00
Surrozen (SRZN) United States $0.035B 0.00
Lipocine (LPCN) United States $0.035B 0.00
Unicycive Therapeutics (UNCY) United States $0.032B 0.00
JanOne (JAN) United States $0.028B 0.00
Oncternal Therapeutics (ONCT) United States $0.027B 0.00
BioVie (BIVI) United States $0.027B 0.00
Viracta Therapeutics (VIRX) United States $0.026B 0.00
TherapeuticsMD (TXMD) United States $0.025B 0.00
Aptorum Group (APM) United Kingdom $0.025B 0.00
Indaptus Therapeutics (INDP) United States $0.024B 0.00
PolyPid (PYPD) Israel $0.022B 0.00
Jaguar Animal Health (JAGX) United States $0.021B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 0.00
Lyra Therapeutics (LYRA) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.019B 0.74
Talphera (TLPH) United States $0.018B 0.00
Alaunos Therapeutics (TCRT) United States $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Nuvilex (PMCB) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.015B 0.00
CERo Therapeutics Holdings (CERO) United States $0.015B 0.00
Mannatech (MTEX) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Dominari Holdings (DOMH) United States $0.013B 0.00
Avalo Therapeutics (AVTX) United States $0.012B 0.00
Plus Therapeutics (PSTV) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.012B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
SHINECO (SISI) China $0.011B 0.00
Biomerica (BMRA) United States $0.011B 0.00
Universe Pharmaceuticals INC (UPC) China $0.010B 0.00
TransCode Therapeutics (RNAZ) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.009B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
PainReform (PRFX) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.31
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 32.47